Efficacy of mepolizumab add-on therapy on health-related quality of life and markers of asthma control in severe eosinophilic asthma (MUSCA): a randomised, double-blind, placebo-controlled, parallel-group, multicentre, phase 3b trial

Autor: Chupp, Geoffrey L, Bradford, Eric S, Albers, Frank C, Bratton, Daniel J, Wang-Jairaj, Jie, Nelsen, Linda M, Trevor, Jennifer L, Magnan, Antoine, ten Brinke, Anneke
Zdroj: In The Lancet Respiratory Medicine May 2017 5(5):390-400
Databáze: ScienceDirect